GS/GN-code 293790 is buiten het toepassingsgebied voor EUDR-voorbereiding.
Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10) De geïndexeerde scope-engine geeft Out of scope terug voor deze code. No Annex I scope match was found for this indexed CN code.
Waarom deze referentiepagina dat antwoord geeft.
- Codeomschrijving
- Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
- Grondslag in bijlage I
- Geen directe vermelding in bijlage I
- Brongrondslag
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Bovenliggende, onderliggende en nabijgelegen rijen.
De bibliotheekweergave dient voor referentienavigatie. Gebruik de checker wanneer u een andere code als actie wilt uitvoeren.
29organische chemische productennarrower2937hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof "incl. chain modified polypeptides", used primarily as hormonesout29379000hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)(2012-2500);hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives)(2002-2011)out293710pituitary "anterior" or similar hormones, and derivatives, used primarily as hormonesout293711somatropin, its derivatives and structural analogues, used primarily as hormonesout293712insulin and its salts, used primarily as hormonesout293719polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)out293721cortisone, hydrocortisone, prednisone "dehydrocortisone" and prednisolone "dehydrohydrocortisone"out293722halogenated derivatives of corticosteroidal hormonesout
Wat dit betekent voor de voorbereiding.
Deze rij is in het huidige scoperesultaat geen directe trigger voor bewijsverzameling.
Regulation (EU) 2023/1115 Annex I — relevant productsopgehaald op 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115opgehaald op 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)opgehaald op 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)opgehaald op 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8opgehaald op 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingopgehaald op 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersopgehaald op 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)opgehaald op 2026-08-08